Recruiting
Phase 2

Epcoritamab & Anti-Neoplastics

Sponsor:

Genmab

Code:

NCT05283720

Conditions

Non-Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Epcoritamab

Lenalidomide

Ibrutinib

Rituximab

Cyclophosphamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information